Prospective audit of exudative age-related macular degeneration: 12-month outcomes in treatment-naive eyes

We report the 12-month outcomes of 1140 treatment-naïve eyes with exudative age-related macular degeneration (wet AMD) who were treated for 12 months with intravitreal anti-VEGF drugs in routine clinical practice. Index visit characteristics, such as lesion type and size, visual acuity (VA, in Logar...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Investigative ophthalmology & visual science 2013-08, Vol.54 (8), p.5754-5760
Hauptverfasser:	Gillies, Mark C, Walton, Richard, Simpson, Judy M, Arnold, Jennifer J, Guymer, Robyn H, McAllister, Ian L, Hunyor, Alex P, Essex, Rohan W, Morlet, Nigel, Barthelmes, Daniel
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Angiogenesis Inhibitors - adverse effects Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Australia Bevacizumab Clinical Audit Exudates and Transudates Female Humans Macular Degeneration - drug therapy Male Prospective Studies Ranibizumab Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!